Revenue for Emcure Pharma Q2 rose by over 20%, totaling ₹2,002 Crore, driven by strong performance across segments.

It has been quite a year for Namita Thapar. “All the hard work we put in for Emcure’s IPO (in July) was super successful.

Emcure Pharma on Monday announced the launch of a public awareness campaign on stroke prevention with cricketer MS Dhoni. The ...

Shares of Emcure Pharma jumped 6 per cent at Rs 1523.80 a piece on the BSE after the company reported a strong second quarter earnings for the financial year 2024-25 (Q2FY25) ...

Shares of Emcure Pharmaceuticals soared close to 6 percent higher, coming at a kissing distance to its record high of Rs ...

Revenue grew by 20.4% YoY to ₹2,002 crore, up from ₹1,663 crore in Q2 last fiscal. The company’s EBITDA rose 15.7% to ₹380.8 ...

Emcure Pharmaceuticals launches Emcutix Biopharmaceuticals, led by industry veteran G. Sathya Narayanan, focusing on ...

Our Bureau, New Delhi Friday, November 8, 2024, 10:30 Hrs [IST] Pune-based Emcure Pharmaceuticals Ltd has posted growth of 38.2 per ...

Emcure Pharmaceuticals Ltd. announces the launch of a public awareness campaign on stroke prevention with cricket legend, MS Dhoni. Under this initiative, Emcure and Dhoni, through a video urge ...

The market is seeing strong growth primarily driven by a growing population. (Image Credits: Pixabay) Emcure Pharmaceuticals Limited on Monday announced that it is set to cater to a growing ...